- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01923350
Avoiding Diabetes After Pregnancy Trial (ADAPT)
Increasing Adoption of Early Intervention to Prevent Diabetes After Gestational Diabetes Mellitus
The Avoiding Diabetes After Pregnancy Trial (ADAPT) study was designed to test the effectiveness of interventions that potentially increase the adoption of Diabetes Prevention Program (DPP) elements by women who had a pregnancy with gestational diabetes mellitus (GDM).
The study was conducted as an integrated trial with two separate arms: one to facilitate weight reduction and the other to increase diabetes testing.
There were two hypotheses:
- Women in the testing intervention will be more likely to have received a diabetes test within the 6 months post-intervention than women in the control group.
- Women in the weight reduction intervention will have lost more weight at the 6-month and 9-month follow-up than women in the control group.
The primary study aim was to determine the efficacy of a system of interactive technology-based supports to prompt women with a history of gestational diabetes to take steps to prevent diabetes. The secondary aims were focused on women's engagement:
- To evaluate the impact of the weight reduction intervention in terms of participant engagement with the interactive technology-based supports.
- To evaluate changes in the women's perception of their personal diabetes risk following after exposure to information about diabetes risk following a pregnancy with GDM.
- To identify the determinants and motivators of and barriers to diabetes testing in the 6- to 12-week postpartum period and thereafter, using the Health Belief model to guide the study.
There was an additional secondary aim involving metformin:
- To evaluate the impact of the diabetes risk reduction intervention in terms of women seeking out their physician's advice on metformin treatment and receiving a metformin prescription, if appropriate.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Maryland
-
Silver Spring, Maryland, United States, 20910
- Social & Scientific Systems Inc.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
General
- History of GDM in the previous 6 months to 4.5 years
- Access to the internet and text messages or phone messages
- Current patient of Harvard Vanguard Medical Associates
- 18 years of age or older
- Able to read in English
Weight Reduction Group
- Overweight or obese
- Capable of performing moderate physical activity
Diabetes Testing Group
- Had not competed a diabetes test (OGTT or fasting blood sugar at 6-12 weeks postpartum or OGTT, fasting blood sugar or hemoglobin A1c after 12 weeks postpartum)
Exclusion Criteria:
General:
- Diabetes diagnosis
- Psychotic disorder diagnosis
- Enrolled in a research study
Weight Reduction Group
- Taking prescription medications for weight loss
- Engaged in a formal weight reduction program
Diabetes Testing Group
- History of postpartum OGTT, fasting plasma glucose or hemoglobin A1c (after 6 weeks postpartum)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Weight Reduction Intervention
|
The weight trial intervention components were:
|
Active Comparator: Weight Reduction Control Arm
|
Participants received an initial brochure about managing diabetes risk, a digital scale to use in entering their weights in online questionnaires, and monthly emailed wellness messages unrelated to diabetes.
|
Active Comparator: Tested for diabetes
|
Due to small numbers in this group, the planned intervention was changed to a mixed-mode study, using baseline and follow-up self-administered questionnaires and semi-structured questionnaires administered to a sub-sample of those tested for diabetes to identify factors differentiating the behavior of women who had and had not been tested for diabetes following a pregnancy with gestational diabetes mellitus.
|
Active Comparator: Not tested for diabetes
|
Due to small numbers in this group, the planned intervention was changed to a mixed-mode study, using baseline and follow-up self-administered questionnaires and semi-structured questionnaires administered to a subsample of those not tested for diabetes to identify factors differentiating the behavior of women who had and had not been tested for diabetes following a pregnancy with gestational diabetes mellitus.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
For participants in weight group, weight reduction from baseline to 6 months
Time Frame: 6 months
|
Participants reported their weights online at baseline, 3 months, 6 months, and 9 months, and the difference in weight from baseline to 6 months was the primary measure of the intervention's success.
|
6 months
|
In testing group, the number of women receiving a diabetes test per ADA Guidelines in the 6-month post-intervention period
Time Frame: 6 months
|
The number of women who were tested in the 6 months following the intervention was determined from electronic medical records.
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Weight intervention participant engagement with the interactive technology-based supports
Time Frame: 9 months
|
Measured by separate scores for taking part in behavioral support (coaching calls) and electronic feedback (women responding on goal performance via daily text messaging (SMS)or weekly IVR, chosen by the participant).
|
9 months
|
Success of participants in weight intervention arm in achieving behavior change goals.
Time Frame: 9 months
|
Information from daily SMS and weekly IVR responses to questions about participants' success in achieving behavior change goals were used to construct achievement scores.
|
9 months
|
Weight change from baseline to 9 months
Time Frame: 9 months
|
Differences were calculated in weights entered on baseline and 9-month surveys for intervention and control arms in the weight group.
|
9 months
|
Weight change from 6 to 9 months
Time Frame: 3 months
|
Difference in weights recorded in 6-month and 9-month questionnaires was calculated for all participants in the weight group.
|
3 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Susan J Griffey, DPh, BSN, Social & Scientific Systems Inc.
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NDEP-GDM GS10F0381L
- GS10F0381L (Other Grant/Funding Number: GSA)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Weight Reduction
-
Marcus SaemannCompletedOverhydration | Dry Weight ReductionAustria
-
Medical Corps, Israel Defense ForceWithdrawnSmoking Cessation | Weight Reduction | Physical Fitness Habits | Balanced Nutrition | Reduction of StressIsrael
-
Tehran University of Medical SciencesCompletedWeight Reduction
-
National Taiwan University HospitalNot yet recruiting
-
Gangnam Severance HospitalUnknownWeight ReductionKorea, Republic of
-
Aga Khan UniversityCompleted
-
Northwestern UniversityCompleted
-
Chin HsuCompleted
-
Oslo Metropolitan UniversityCompleted
-
Institute of Mental Health, SingaporeCompletedAntipsychotics Weight GainSingapore
Clinical Trials on Weight Reduction Intervention
-
University of PennsylvaniaNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Chulalongkorn UniversityUnknown
-
Assaf-Harofeh Medical CenterUnknownSpontaneous Osteonecrosis of the KneeIsrael
-
Chinese Academy of SciencesSir Run Run Shaw HospitalRecruitingHealthy | Obesity | Metabolism and Nutrition Disorder | HomeostasisChina
-
Göteborg UniversityCompletedPolycystic Ovary SyndromeSweden
-
The University of Tennessee, KnoxvilleCompleted
-
Sheffield Teaching Hospitals NHS Foundation TrustCompleted
-
Health Education Research Foundation (HERF)CompletedObesity | Emotional EatingPakistan
-
Helmholtz Centre for Environmental Research - UFZDuke University; Seoul National University; University Hospital, AntwerpNot yet recruitingExposure to PollutionGermany
-
Hospital Authority, Hong KongThe University of Hong KongCompleted